| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/30/2008 | CA2250295C Water soluble paclitaxel prodrugs |
| 12/30/2008 | CA2218929C Compositions in glassy phase, stabilised by a sugar |
| 12/30/2008 | CA2189351C Narcotic containing aerosol formulation |
| 12/30/2008 | CA2144425C Microparticules bearing antigens and their use for the introduction of humoral and cell responses |
| 12/30/2008 | CA2132349C Chimeric receptor genes and cells transformed therewith |
| 12/25/2008 | US20080319167 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 12/25/2008 | US20080319092 Transdermal Drug Delivery Formulation |
| 12/25/2008 | US20080319091 Polymer Derivatives Comprising an Imide Branching Point |
| 12/25/2008 | US20080319090 Pearlizer concentrate and its use in personal care compositions |
| 12/25/2008 | US20080318918 Methods for Treatment and Prevention of Otitis Media Using Nonionic Surfactants to Facilitate Transmembrane Drug Delivery into the Middle Ear |
| 12/25/2008 | US20080318898 Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof |
| 12/25/2008 | US20080318879 Method for the Preparation of Polymeric Conjugates of Doxorubicin with Ph-Controlled Release of the Drug |
| 12/25/2008 | US20080318863 Ischemia therapeutic agent |
| 12/25/2008 | US20080318862 Crosslinkable polymeric materials and their applications |
| 12/25/2008 | US20080318254 PSCA antibodies and hybridomas producing them |
| 12/25/2008 | US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 12/25/2008 | US20080318245 Alumina; phopholipid; arrays, membrane biochips, and protein biochips; affinity purification, catalysis |
| 12/25/2008 | US20080318239 Compositions and methods for the diagnosis and treatment of tumor |
| 12/25/2008 | US20080317888 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis |
| 12/25/2008 | US20080317861 Polymeric Materials and Methods |
| 12/25/2008 | US20080317851 Immediate release dosage forms containing solid drug disbursions |
| 12/25/2008 | US20080317850 Buccal Delivery System |
| 12/25/2008 | US20080317848 Side effect reduction; retarder coating; embedded in matrix; sustained release |
| 12/25/2008 | US20080317847 Hydrostatic delivery system for controlled delivery of agent |
| 12/25/2008 | US20080317834 Compounds and methods for modulating cerebral amyloid angiopathy |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/25/2008 | US20080317827 Methods and Devices for Delivering Therapeutic Agents to Target Vessels |
| 12/25/2008 | US20080317823 High Pressure Processing of Bioactive Compositions |
| 12/25/2008 | US20080317789 Carrageenan Process |
| 12/25/2008 | US20080317783 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317782 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 12/25/2008 | US20080317773 Conjugates that contain the homeodomain of antennapedia |
| 12/25/2008 | US20080317767 Tripartitle Raftophilic Strutures and their Use |
| 12/25/2008 | US20080317747 Recombinant anti-cd30 antibodies and uses thereof |
| 12/25/2008 | US20080317735 Pharmaceutical preparation with RNA as hemostasis cofactor |
| 12/25/2008 | US20080317707 Pegylated interleukin-10 |
| 12/25/2008 | US20080317690 Dermatological or oral disease; drug delivery; sustained release; onychomycosis; contains benzoin, a topical active agent and a volatile solvent like ethanol |
| 12/25/2008 | US20080317687 Cosmetic and pharmaceutical oil-in-water emulsions containing an ester quat |
| 12/25/2008 | US20080317684 Topical Compositions |
| 12/24/2008 | WO2008157824A2 Thrombopoietin peptide conjugates |
| 12/24/2008 | WO2008157288A2 A baclofen solution for low-volume therapeutic delivery |
| 12/24/2008 | WO2008156356A1 Preparation of a pharmaceutically active ingredient comprising a desolventising step |
| 12/24/2008 | WO2008156109A1 Chitin slurry and method for producing the same |
| 12/24/2008 | WO2008156103A1 Dried gel product, mixture, orally administrable pharmaceutical formulation, and method for preparing orally administrable pharmaceutical formulation |
| 12/24/2008 | WO2008156027A1 Non-transparent coating composition |
| 12/24/2008 | WO2008155487A2 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x |
| 12/24/2008 | WO2008155345A1 Mouthwash composition comprising xanthan gum and sodium fluoride |
| 12/24/2008 | WO2008135674A3 Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof |
| 12/24/2008 | WO2008133789A3 Methods and compositions for targeting afap |
| 12/24/2008 | WO2008112289A3 Oligomer-protease inhibitor conjugates |
| 12/24/2008 | WO2008112288A3 Oligomer-opioid agonist conjugates |
| 12/24/2008 | WO2008101179A3 Use of sucrose to suppress mannitol-induced protein aggregation |
| 12/24/2008 | WO2008100807A3 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/24/2008 | WO2008084411A3 Modified saccharides |
| 12/24/2008 | WO2008079732A3 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 12/24/2008 | WO2008062209A3 Dissolution and processing of cellulose |
| 12/24/2008 | WO2008051291A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 12/24/2008 | WO2008042802A3 Wet edible pearlescent film coatings |
| 12/24/2008 | WO2008012086A3 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 12/24/2008 | WO2007144048A3 Presentation form for the oral administration of phenothiazine dyes, its production and use |
| 12/24/2008 | EP2006321A1 Synthesis and application of a family of new materials resulting from the chemical cross-linking between gelatine and organic salts |
| 12/24/2008 | EP2005990A2 Microneedle device and transdermal administration device provided with microneedles |
| 12/24/2008 | EP2005968A2 Nanocomposite particle |
| 12/24/2008 | EP2005959A1 External pharmaceutical composition |
| 12/24/2008 | EP2005958A1 External pharmaceutical composition |
| 12/24/2008 | EP2005956A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 12/24/2008 | EP2005952A1 Tamsulosin-containing percutaneous absorption type preparation |
| 12/24/2008 | EP2005946A1 Method for producing extended release tablet |
| 12/24/2008 | EP2005944A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 12/24/2008 | EP2004721A1 Novel o-carboxy anhydrides (ocas) comprising a salifiable function and polymers obtained from these ocas |
| 12/24/2008 | EP2004696A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 12/24/2008 | EP2004693A2 Compositions and methods of use for antibodies of c-met |
| 12/24/2008 | EP2004642A1 Bifunctional polyazamacrocyclic chelating agents |
| 12/24/2008 | EP2004238A2 Peptide-peptidase inhibitor conjugates and methods of using same |
| 12/24/2008 | EP2004237A1 Targeted therapy |
| 12/24/2008 | EP2004236A2 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
| 12/24/2008 | EP2004235A2 Composition for cosmetic or pharmaceutical-dermatological use |
| 12/24/2008 | EP2004231A2 Conjugates of an anti-tnf-alpha antibody |
| 12/24/2008 | EP2004226A1 Storage of influenza vaccines without refrigeration |
| 12/24/2008 | EP2004221A2 Anti-tumor cell antigen antibody therapeutics |
| 12/24/2008 | EP2004147A2 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| 12/24/2008 | EP2004146A1 A tablet of paracetamol containing an encapsulated flavorant |
| 12/24/2008 | EP2004142A2 Enhancing solubility and dissolution rate of poorly soluble drugs |
| 12/24/2008 | EP2004138A1 Gastric raft composition comprising preferably processed starches for inducing satiety |
| 12/24/2008 | EP2003990A2 Association of oleaginous substance with a mixture of at least two cyclodextrins |
| 12/24/2008 | EP2003970A2 Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin |
| 12/24/2008 | EP1706095B1 Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 12/24/2008 | EP1581181B1 Controlled release depot formulations |
| 12/24/2008 | EP1562568B1 Treatment of heaves |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1379219B1 Large, porous particles produced by controlling humidity during a spray draying process |
| 12/24/2008 | EP1368061B1 Fusion cells and cytokine compositions for treatment of disease |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | EP0909277B2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/24/2008 | DE202007018629U1 Flüssigformulierung von G-CSF Liquid formulation of G-CSF |
| 12/24/2008 | DE102008012457A1 Hydrocarbon mixture, useful e.g. in decorative cosmetics, preferably lipsticks, lip gloss, eye shade, mascara, eye pencil, nail polish and make-up formulations and eye shade, comprises linear hydrocarbons |
| 12/24/2008 | CN101331173A Biocompatible block copolymer, use thereof, and production method thereof |
| 12/24/2008 | CN101330931A Production of conjugates |
| 12/24/2008 | CN101330910A Bisoprolol-containing adhesive patch |
| 12/24/2008 | CN101330908A Adhesive preparation |